Correlation Between Clonal Hematopoiesis, Cardio-vascular Events, Inflammation and Atherosclerosis

Inclusion Criteria: * Patients (male or female) over 75 years old * Patients with a first CVE (myocardial infarction) of atheromatous origin that occurred between 2 and 7 months before inclusion * Absence of evidence of hematological malignancy (known or obvious by the results of blood counts) * Subject registered with a social security scheme * Written informed consent obtained Exclusion Criteria: * Patients who did not presented any CVE in the last 7 months * Patients with CVE with a non-atheromatous origin (dissection, embolic, …) * Presence of an unbalanced diabetes (defined as HbA1C \> 10%) * History of previous CVE before 75 year-old : myocardial infarction, stroke of atheromatous origin * Hematological malignancy (known or obvious on the results of blood counts) * Chronic inflammatory disease (cancer, vasculitis, rheumatism, hepato-gastro-intestinal diseases). * Long term anti-inflammatory treatments: * Corticoids * Nonsteroidal anti-inflammatory drugs * Aspirin (\> 325 mg per day) * Cyclo-oxygenase II inhibitors * Persons under judicial safeguards, trustee or curators * Person deprived of judicial or administrative freedom * Person unable to give her consent * Non-cooperative person * Exclusion period after another clinical study or participation to another interventional clinical study testing a drug in the 30 days before inclusion